Compass Therapeutics, Inc. Stock
Stocks
CMPX
US20454B1044
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Nasdaq
16:00:00 2026-10-12 EDT
|
5-day change | 1st Jan Change | ||
| 0.9375 USD | -5.59% |
|
-2.40% | -82.54% |
| 09-23 | Compass Therapeutics Shares Drop After Downgrade From Wedbush | MT |
| 09-23 | Wedbush Downgrades Compass Therapeutics to Neutral From Outperform, Cuts Price Target to $1 From $5 | MT |
| Market Cap | 179M 160M 149M 135M 255M 17.09B 257M 1.79B 702M 8.82B 672M 657M 28.39B | P/E 2026 * |
-2x | P/E 2027 * | -1.78x |
|---|---|---|---|---|---|
| Enterprise Value | 28.83M 25.81M 24.06M 21.82M 41.16M 2.76B 41.41M 289M 113M 1.42B 108M 106M 4.58B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 7.04x |
| Free-Float |
87.53% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| CMPX | Delayed | |
CBOE
| CMPX | Real-time |
Last Transcript: Compass Therapeutics, Inc.
| 1 day | -5.59% | ||
| 1 week | -2.40% | ||
| Current month | -9.86% | ||
| 1 month | -52.17% | ||
| 3 months | -58.52% | ||
| 6 months | -81.97% | ||
| Current year | -82.54% |
| 1 week | 0.92 |  | 1.06 |
| 1 month | 0.83 | | 2.04 |
| Current year | 0.83 | | 6.88 |
| 1 year | 0.83 | | 6.88 |
| 3 years | 0.76 | | 6.88 |
| 5 years | 0.76 | | 6.88 |
| 10 years | 0.76 | | 11 |
| Manager | Title | Age | Since |
|---|---|---|---|
Thomas Schuetz
CEO | Chief Executive Officer | 65 | 2024-05-27 |
Barry Shin
DFI | Director of Finance/CFO | 54 | 2024-12-08 |
Bing Gong
CTO | Chief Tech/Sci/R&D Officer | 50 | 2025-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Thomas Schuetz
BRD | Director/Board Member | 65 | 2013-12-31 |
Phil Ferneau
BRD | Director/Board Member | 64 | 2014-12-31 |
Carl Gordon
CHM | Chairman | 61 | 2014-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/1/26 | Buy | Controller/Auditor | 20,000 | 0.0111% | ||
| 9/24/26 | Buy | Controller/Auditor | 2,500 | 0.0014% | ||
| 4/29/26 | Buy | Controller/Auditor | 15,000 | 0.0083% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -5.59% | -2.40% | -78.12% | -49.87% | 179M | |
| +0.03% | -5.67% | +50.74% | +79.07% | 70.61B | |
| +0.66% | -10.08% | +6.97% | +54.49% | 51.01B | |
| +0.31% | +1.49% | +8.84% | +32.81% | 48.1B | |
| +0.90% | -1.46% | +28.68% | +32.69% | 42.78B | |
| +2.21% | -6.61% | +297.85% | +701.45% | 40.67B | |
| -1.15% | -3.11% | +7.15% | +98.83% | 40.3B | |
| +0.45% | -1.20% | +9.11% | +46.80% | 30.59B | |
| -2.23% | -3.48% | +39.06% | +12.14% | 28.16B | |
| -1.16% | -1.84% | -6.31% | -11.99% | 24.36B | |
| Average | -0.56% | -0.63% | +36.40% | +99.64% | 37.68B | |
| Weighted average by Cap. | +0.14% | -2.72% | +50.97% | +120.30% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 6.51M 5.83M 5.43M 4.93M 9.3M 622M 9.36M 65.31M 25.57M 321M 24.46M 23.92M 1.03B |
| Net income | -93.27M -83.49M -77.83M -70.6M -133M -8.92B -134M -935M -366M -4.6B -350M -343M -14.81B | -112M -100M -93.23M -84.56M -159M -10.68B -160M -1.12B -439M -5.51B -420M -410M -17.73B |
| Net Debt | -150M -134M -125M -114M -214M -14.34B -215M -1.5B -589M -7.4B -563M -551M -23.81B | -133M -119M -111M -101M -190M -12.71B -191M -1.33B -522M -6.56B -500M -489M -21.11B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-12 | US$0.9375 | -5.59% | 4,433,457 |
| 26-10-09 | US$0.9930 | +0.98% | 3,670,889 |
| 26-10-08 | US$0.9834 | -3.59% | 7,042,690 |
| 26-10-07 | US$1.020 | +2.19% | 2,792,590 |
| 26-10-06 | US$0.9981 | +3.90% | 7,286,326 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CMPX Stock
Select your edition
All financial news and data tailored to specific country editions
